{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:04:38Z","timestamp":1795043078915,"version":"4.10.2"},"reference-count":476,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8S","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1097\/tp.0000000000001769","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T16:17:11Z","timestamp":1500999431000},"page":"S7-S105","source":"Crossref","is-referenced-by-count":268,"title":["KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors"],"prefix":"10.1097","volume":"101","author":[{"given":"Krista L.","family":"Lentine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram L.","family":"Kasiske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Alber\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Bakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Gallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Garvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Guleria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Kam-Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorry L.","family":"Segev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra J.","family":"Taler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Zeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit X.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210211","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/sj.ki.5001875","article-title":"Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"70","author":"Uhlig","year":"2006","journal-title":"Kidney Int"},{"key":"R2-6-20210211","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/01.TP.0000136654.85459.1E","article-title":"The consensus statement of the Amsterdam Forum on the Care of the Live Kidney Donor.","volume":"78","year":"2004","journal-title":"Transplantation"},{"key":"R3-6-20210211","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/TP.0000000000001252","article-title":"Long-term outcomes of living kidney donation","volume":"100","author":"Slinin","year":"2016","journal-title":"Transplantation"},{"key":"R4-6-20210211","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1681\/ASN.2016050571","article-title":"Understanding and communicating medical risks for living kidney donors: a matter of perspective","volume":"28","author":"Lentine","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R7-6-20210211","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1510491","article-title":"Kidney-failure risk projection for the living kidney-donor candidate","volume":"374","author":"Grams","year":"2016","journal-title":"N Engl J Med"},{"key":"R8-6-20210211","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/ajt.13540","article-title":"Estimated GFR for living kidney donor evaluation","volume":"16","author":"Huang","year":"2016","journal-title":"Am J Transplant"},{"key":"R9-6-20210211","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R10-6-20210211","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"R11-6-20210211","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jclinepi.2014.12.011","article-title":"Guideline panels should not GRADE good practice statements","volume":"68","author":"Guyatt","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"R12-6-20210211","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/qhc.12.1.18","article-title":"Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project.","volume":"12","year":"2003","journal-title":"Qual Saf Health Care"},{"key":"R13-6-20210211","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-139-6-200309160-00013","article-title":"Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization","volume":"139","author":"Shiffman","year":"2003","journal-title":"Ann Intern Med"},{"key":"R16-6-20210211","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1111\/ajt.13272","article-title":"Development of a donor-centered approach to risk assessment: rebalancing nonmaleficence and autonomy","volume":"15","author":"Thiessen","year":"2015","journal-title":"Am J Transplant"},{"key":"R18-6-20210211","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1001\/jama.284.22.2919","article-title":"Consensus statement on the live organ donor","volume":"284","author":"Abecassis","year":"2000","journal-title":"JAMA"},{"key":"R19-6-20210211","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1111\/ajt.12411","article-title":"Living kidney donor assessment: challenges, uncertainties and controversies among transplant nephrologists and surgeons","volume":"13","author":"Tong","year":"2013","journal-title":"Am J Transplant"},{"key":"R20-6-20210211","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/TP.0b013e3182328276","article-title":"Screening and follow-up of living kidney donors: a systematic review of clinical practice guidelines","volume":"92","author":"Tong","year":"2011","journal-title":"Transplantation"},{"key":"R21-6-20210211","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/TP.0000000000000994","article-title":"long-term outcome of living kidney donation: position paper of the European Committee on Organ Transplantation, Council of Europe","volume":"100","author":"Cozzi","year":"2016","journal-title":"Transplantation"},{"key":"R22-6-20210211","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2215\/CJN.02180606","article-title":"Creating a medical, ethical, and legal framework for complex living kidney donors","volume":"1","author":"Reese","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-6-20210211","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2010.237","article-title":"Perioperative mortality and long-term survival following live kidney donation","volume":"303","author":"Segev","year":"2010","journal-title":"JAMA"},{"key":"R24-6-20210211","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1046\/j.1038-5282.2001.00400.x-i1","article-title":"Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers","volume":"3","author":"Matas","year":"2003","journal-title":"Am J Transplant"},{"key":"R25-6-20210211","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2007.01975.x","article-title":"2509 living donor nephrectomies, morbidity and mortality, including the UK introduction of laparoscopic donor surgery","volume":"7","author":"Hadjianastassiou","year":"2007","journal-title":"Am J Transplant"},{"key":"R26-6-20210211","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/j.1600-6143.2008.02339.x","article-title":"Health outcomes for living kidney donors with isolated medical abnormalities: a systematic review","volume":"8","author":"Young","year":"2008","journal-title":"Am J Transplant"},{"key":"R27-6-20210211","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ki.2012.485","article-title":"Systematic review and meta-analysis of the relation between body mass index and short-term donor outcome of laparoscopic donor nephrectomy","volume":"83","author":"Lafranca","year":"2013","journal-title":"Kidney Int"},{"key":"R28-6-20210211","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.2215\/CJN.12311212","article-title":"Comorbidity burden and perioperative complications for living kidney donors in the United States","volume":"8","author":"Schold","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R29-6-20210211","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/ajt.13687","article-title":"Perioperative complications after living kidney donation: a national study","volume":"16","author":"Lentine","year":"2016","journal-title":"Am J Transplant"},{"key":"R30-6-20210211","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.2013.285141","article-title":"Risk of end-stage renal disease following live kidney donation","volume":"311","author":"Muzaale","year":"2014","journal-title":"JAMA"},{"key":"R31-6-20210211","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1111\/ajt.13917","article-title":"Patterns of end-stage renal disease caused by diabetes, hypertension, and glomerulonephritis in live kidney donors","volume":"16","author":"Anjum","year":"2016","journal-title":"Am J Transplant"},{"key":"R32-6-20210211","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2013.460","article-title":"Long-term risks for kidney donors","volume":"86","author":"Mjoen","year":"2014","journal-title":"Kidney Int"},{"key":"R33-6-20210211","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/MNH.0000000000000063","article-title":"End-stage renal disease risk in live kidney donors: what have we learned from two recent studies?","volume":"23","author":"Lam","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R34-6-20210211","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrneph.2015.58","article-title":"Long-term medical risks to the living kidney donor","volume":"11","author":"Lam","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"R35-6-20210211","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/01.ASN.0000014251.87778.01","article-title":"Cumulative risk for developing end-stage renal disease in the US population","volume":"13","author":"Kiberd","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R36-6-20210211","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJMe1513891","article-title":"The risks of living kidney donation","volume":"374","author":"Steiner","year":"2016","journal-title":"N Engl J Med"},{"key":"R37-6-20210211","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1056\/NEJMoa1510491","article-title":"Kidney-failure risk projection for the living kidney-donor candidate","volume":"374","author":"Grams","year":"2016","journal-title":"N Engl J Med"},{"key":"R38-6-20210211","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1097\/01.TP.0000157343.27949.9F","article-title":"A report of the Amsterdam forum on the care of the live kidney donor: data and medical guidelines","volume":"79","author":"Delmonico","year":"2005","journal-title":"Transplantation"},{"key":"R39-6-20210211","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40472-014-0044-3","article-title":"Informed consent of living kidney donors: pitfalls and best practice","volume":"2","author":"Hays","year":"2015","journal-title":"Curr Transpl Rep"},{"key":"R40-6-20210211","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1111\/ajt.12406","article-title":"Written informed consent for living kidney donors: practices and compliance with CMS and OPTN requirements","volume":"13","author":"Thiessen","year":"2013","journal-title":"Am J Transplant"},{"key":"R41-6-20210211","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1399-0012.2010.01374.x","article-title":"Assessing elements of informed consent among living donors","volume":"25","author":"Valapour","year":"2011","journal-title":"Clin Transplant"},{"key":"R42-6-20210211","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/j.1600-6143.2012.04102.x","article-title":"Informed consent for living donation: a review of key empirical studies, ethical challenges and future research","volume":"12","author":"Gordon","year":"2012","journal-title":"Am J Transplant"},{"key":"R43-6-20210211","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1093\/ndt\/gfm305","article-title":"Transplant professionals vary in the long-term medical risks they communicate to potential living kidney donors: an international survey","volume":"22","author":"Housawi","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R44-6-20210211","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1111\/j.1600-6143.2007.01921.x","article-title":"Evaluating living kidney donors: relationship types, psychosocial criteria, and consent processes at US transplant programs","volume":"7","author":"Rodrigue","year":"2007","journal-title":"Am J Transplant"},{"key":"R45-6-20210211","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/ajt.12195","article-title":"Opportunities for shared decision making in kidney transplantation","volume":"13","author":"Gordon","year":"2013","journal-title":"Am J Transplant"},{"key":"R46-6-20210211","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1600-6143.2007.01751.x","article-title":"Guidelines for the psychosocial evaluation of living unrelated kidney donors in the United States","volume":"7","author":"Dew","year":"2007","journal-title":"Am J Transplant"},{"key":"R50-6-20210211","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/ndt\/gfu216","article-title":"European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care","volume":"30","author":"Abramowicz","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"R53-6-20210211","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/ajt.12307","article-title":"How young is too young to be a living donor?","volume":"13","author":"Campbell","year":"2013","journal-title":"Am J Transplant"},{"key":"R54-6-20210211","first-page":"1","article-title":"E.N.) and Spanish Transplant Organisation (ONT). Recommendations for living-donor kidney transplantation.","volume":"30","year":"2010","journal-title":"Nefrologia"},{"key":"R55-6-20210211","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.eururo.2004.02.009","article-title":"EAU guidelines on renal transplantation","volume":"47","author":"K\u00e4lble","year":"2005","journal-title":"Eur Urol"},{"key":"R58-6-20210211","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2215\/CJN.01030115","article-title":"Living donor kidney transplantation: facilitating education about live kidney donation\u2014recommendations from a consensus conference","volume":"10","author":"Tan","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R59-6-20210211","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/oxfordjournals.ndt.a027990","article-title":"Section II: Evaluation and selection of donors.","volume":"15","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R60-6-20210211","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/ajt.12140","article-title":"Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference","volume":"13","author":"Melcher","year":"2013","journal-title":"Am J Transplant"},{"key":"R62-6-20210211","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/TP.0b013e31827e31f7","article-title":"Anonymity and live-donor transplantation: an ELPAT view","volume":"95","author":"Mamode","year":"2013","journal-title":"Transplantation"},{"key":"R63-6-20210211","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/j.1600-6143.2012.04070.x","article-title":"Single-center kidney paired donation: the Methodist San Antonio experience","volume":"12","author":"Bingaman","year":"2012","journal-title":"Am J Transplant"},{"key":"R64-6-20210211","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1097\/TP.0000000000000533","article-title":"Willingness of directed living donors and their recipients to participate in kidney paired donation programs","volume":"99","author":"Hendren","year":"2015","journal-title":"Transplantation"},{"key":"R65-6-20210211","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/ajt.13218","article-title":"Equipoise: ethical, scientific, and clinical trial design considerations for compatible pair participation in kidney exchange programs","volume":"15","author":"Cuffy","year":"2015","journal-title":"Am J Transplant"},{"key":"R66-6-20210211","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/TP.0b013e3181a4eae5","article-title":"Discovering misattributed paternity in living kidney donation: prevalence, preference, and practice","volume":"87","author":"Young","year":"2009","journal-title":"Transplantation"},{"key":"R67-6-20210211","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1600-6143.2009.03011.x","article-title":"Good ethics requires good science: why transplant programs should not disclose misattributed parentage","volume":"10","author":"Ross","year":"2010","journal-title":"Am J Transplant"},{"key":"R68-6-20210211","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1525-139X.2002.00541.x","article-title":"Disclosure of misattributed paternity: issues involved in the discovery of unsought information","volume":"15","author":"Wright","year":"2002","journal-title":"Semin Dial"},{"key":"R69-6-20210211","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2215\/CJN.02280215","article-title":"Disclosing health and health behavior information between living donors and their recipients","volume":"10","author":"Mataya","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R70-6-20210211","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2215\/CJN.06130809","article-title":"Attitudes to sharing personal health information in living kidney donation","volume":"5","author":"Hizo-Abes","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R71-6-20210211","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/ajt.12386","article-title":"Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation","volume":"13","author":"Seem","year":"2013","journal-title":"Am J Transplant"},{"key":"R72-6-20210211","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1600-6143.2011.03580.x","article-title":"Disclosing recipient information to potential living donors: preferences of donors and recipients, before and after surgery","volume":"11","author":"Rodrigue","year":"2011","journal-title":"Am J Transplant"},{"key":"R74-6-20210211","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/TP.0b013e318295ee7d","article-title":"Organ trafficking and transplant tourism: the role of global professional ethical standards\u2014the 2008 Declaration of Istanbul","volume":"95","author":"Danovitch","year":"2013","journal-title":"Transplantation"},{"key":"R75-6-20210211","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/ajt.12599","article-title":"What are the harms of refusing to allow living kidney donation? An expanded view of risks and benefits","volume":"14","author":"Allen","year":"2014","journal-title":"Am J Transplant"},{"key":"R77-6-20210211","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/lt.24175","article-title":"Optimizing informed consent in living liver donors: evaluation of a comprehension assessment tool","volume":"21","author":"Gordon","year":"2015","journal-title":"Liver Transpl"},{"key":"R78-6-20210211","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s10880-015-9424-9","article-title":"Patient-reported outcomes following living kidney donation: a single center experience","volume":"22","author":"Rodrigue","year":"2015","journal-title":"J Clin Psychol Med Settings"},{"key":"R80-6-20210211","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.transproceed.2008.11.005","article-title":"Prisoners as organ donors: is it worth the effort? Is it ethical?","volume":"41","author":"Millis","year":"2009","journal-title":"Transplant Proc"},{"key":"R81-6-20210211","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1600-6143.2009.03010.x","article-title":"What the medical excuse teaches us about the potential living donor as patient","volume":"10","author":"Ross","year":"2010","journal-title":"Am J Transplant"},{"key":"R82-6-20210211","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/medethics-2014-102184","article-title":"Opting out: confidentiality and availability of an 'alibi' for potential living kidney donors in the USA","volume":"41","author":"Thiessen","year":"2015","journal-title":"J Med Ethics"},{"key":"R83-6-20210211","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/jme.2009.031740","article-title":"Understanding risk in living donor nephrectomy","volume":"36","author":"Maple","year":"2010","journal-title":"J Med Ethics"},{"key":"R84-6-20210211","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/TP.0000000000001514","article-title":"Public solicitation of anonymous organ donors: a position paper by the Canadian Society of Transplantation","volume":"101","author":"Fortin","year":"2017","journal-title":"Transplantation"},{"key":"R85-6-20210211","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1097\/01.tp.0000295931.39616.25","article-title":"Probabilistic risk assessment of accidental ABO-incompatible thoracic organ transplantation before and after 2003","volume":"84","author":"Cook","year":"2007","journal-title":"Transplantation"},{"key":"R86-6-20210211","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/01.TP.0000058226.39732.32","article-title":"ABO-incompatible kidney transplantation using both A2 and non-A2 living donors","volume":"75","author":"Gloor","year":"2003","journal-title":"Transplantation"},{"key":"R87-6-20210211","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/TP.0000000000000821","article-title":"Deleterious impact of donor-specific anti-HLA antibodies toward HLA-Cw and HLA-DP in kidney transplantation","volume":"100","author":"Bachelet","year":"2016","journal-title":"Transplantation"},{"key":"R88-6-20210211","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.ajkd.2015.03.033","article-title":"Humoral immune response and allograft function in kidney transplantation","volume":"66","author":"Filippone","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R89-6-20210211","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"R90-6-20210211","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/j.1600-6143.2005.01048.x","article-title":"Characterization of waiting times in a simulation of kidney paired donation","volume":"5","author":"Segev","year":"2005","journal-title":"Am J Transplant"},{"key":"R91-6-20210211","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/TP.0b013e318245b2af","article-title":"Outcomes of ABO-incompatible kidney transplantation in the United States","volume":"93","author":"Montgomery","year":"2012","journal-title":"Transplantation"},{"key":"R92-6-20210211","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"R93-6-20210211","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.293.15.1883","article-title":"Kidney paired donation and optimizing the use of live donor organs","volume":"293","author":"Segev","year":"2005","journal-title":"JAMA"},{"key":"R94-6-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ajt.13195","article-title":"OPTN\/SRTR 2013 Annual Data Report: kidney","volume":"15","author":"Matas","year":"2015","journal-title":"Am J Transplant"},{"key":"R95-6-20210211","first-page":"130","article-title":"[Favourable results of the first 2 years of the Dutch paired, living donor, kidney exchange programme","volume":"151","author":"de Klerk","year":"2007","journal-title":"Ned Tijdschr Geneeskd"},{"key":"R96-6-20210211","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1600-6143.2010.03386.x","article-title":"Transporting live donor kidneys for kidney paired donation: initial national results","volume":"11","author":"Segev","year":"2011","journal-title":"Am J Transplant"},{"key":"R97-6-20210211","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/tri.12405","article-title":"Outcomes of shipped live donor kidney transplants compared with traditional living donor kidney transplants","volume":"27","author":"Treat","year":"2014","journal-title":"Transpl Int"},{"key":"R98-6-20210211","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/j.1600-6143.2012.04156.x","article-title":"Chain transplantation: initial experience of a large multicenter program","volume":"12","author":"Melcher","year":"2012","journal-title":"Am J Transplant"},{"key":"R99-6-20210211","doi-asserted-by":"crossref","first-page":"22","DOI":"10.6061\/clinics\/2014(Sup01)05","article-title":"ABO-incompatible living-donor pediatric kidney transplantation in Japan","volume":"69","author":"Aikawa","year":"2014","journal-title":"Clinics (Sao Paulo"},{"key":"R100-6-20210211","first-page":"18","article-title":"Trends in ABO-incompatible kidney transplantation","volume":"13","author":"Aikawa","year":"2015","journal-title":"Exp Clin Transplant"},{"key":"R101-6-20210211","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1600-6143.2004.00464.x","article-title":"Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan","volume":"4","author":"Takahashi","year":"2004","journal-title":"Am J Transplant"},{"key":"R102-6-20210211","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/TP.0000000000000029","article-title":"Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients","volume":"98","author":"Lentine","year":"2014","journal-title":"Transplantation"},{"key":"R103-6-20210211","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.transproceed.2013.02.028","article-title":"Kidney transplantation of living unrelated and ABO-incompatible donor-recipient combinations","volume":"45","author":"Ishikawa","year":"2013","journal-title":"Transplant Proc"},{"key":"R104-6-20210211","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/ctr.12249","article-title":"ABO incompatible living donor kidney transplantation in Korea: highly uniform protocols and good medium-term outcome","volume":"27","author":"Kong","year":"2013","journal-title":"Clin Transplant"},{"key":"R105-6-20210211","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/TP.0b013e31819f2024","article-title":"ABO incompatible renal transplantation: a paradigm ready for broad implementation","volume":"87","author":"Montgomery","year":"2009","journal-title":"Transplantation"},{"key":"R106-6-20210211","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/TP.0000000000000312","article-title":"Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers","volume":"99","author":"Opelz","year":"2015","journal-title":"Transplantation"},{"key":"R108-6-20210211","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/ajt.13616","article-title":"Economic impacts of ABO-incompatible live donor kidney transplantation: A national study of Medicare-insured recipients","volume":"16","author":"Axelrod","year":"2016","journal-title":"Am J Transplant"},{"key":"R109-6-20210211","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJMoa1508380","article-title":"Survival benefit with kidney transplants from HLA-incompatible live donors","volume":"374","author":"Orandi","year":"2016","journal-title":"N Engl J Med"},{"key":"R111-6-20210211","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"R112-6-20210211","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/TP.0b013e3181bb44fd","article-title":"Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry","volume":"88","author":"Mj\u00f8en","year":"2009","journal-title":"Transplantation"},{"key":"R113-6-20210211","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/ajt.14033","article-title":"Predonation prescription opioid use: a novel risk factor for readmission after living kidney donation","volume":"17","author":"Lentine","year":"2017","journal-title":"Am J Transplant"},{"key":"R114-6-20210211","doi-asserted-by":"crossref","first-page":"ITC81","DOI":"10.7326\/AITC201612060","article-title":"Preoperative evaluation for noncardiac surgery","volume":"165","author":"Cohn","year":"2016","journal-title":"Ann Intern Med"},{"key":"R115-6-20210211","first-page":"e418","article-title":"ACC\/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery","volume":"116","author":"Fleisher","year":"2007","journal-title":"Circulation"},{"key":"R116-6-20210211","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jacc.2010.10.055","article-title":"Systematic review of guidelines on imaging of asymptomatic coronary artery disease","volume":"57","author":"Ferket","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R117-6-20210211","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2141.2007.06968.x","article-title":"Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology","volume":"140","author":"Chee","year":"2008","journal-title":"Br J Haematol"},{"key":"R118-6-20210211","first-page":"1","article-title":"[Objectives and methodology of S.E.N-ONT guidelines for living donor kidney transplantation]","volume":"30","author":"Fern\u00e1ndez Fresnedo","year":"2010","journal-title":"Nefrologia"},{"key":"R119-6-20210211","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJMoa1401105","article-title":"Aspirin in patients undergoing noncardiac surgery","volume":"370","author":"Devereaux","year":"2014","journal-title":"N Engl J Med"},{"key":"R120-6-20210211","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"key":"R121-6-20210211","doi-asserted-by":"crossref","first-page":"575","DOI":"10.7326\/0003-4819-144-8-200604180-00008","article-title":"Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians","volume":"144","author":"Qaseem","year":"2006","journal-title":"Ann Intern Med"},{"key":"R122-6-20210211","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/ALN.0000000000000053","article-title":"Practice guidelines for the perioperative management of patients with obstructive sleep apnea: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea.","volume":"120","year":"2014","journal-title":"Anesthesiology"},{"key":"R123-6-20210211","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.amjmed.2010.09.013","article-title":"Smoking cessation reduces postoperative complications: a systematic review and meta-analysis","volume":"124","author":"Mills","year":"2011","journal-title":"Am J Med"},{"key":"R125-6-20210211","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-156-11-201203200-00391","article-title":"Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review","volume":"156","author":"Earley","year":"2012","journal-title":"Ann Intern Med"},{"key":"R127-6-20210211","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.ajkd.2011.06.012","article-title":"Level and determinants of kidney function in a South Asian population in Pakistan","volume":"58","author":"Jafar","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R128-6-20210211","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R129-6-20210211","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/j.ajkd.2014.04.010","article-title":"Measuring GFR: a systematic review","volume":"64","author":"Soveri","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R130-6-20210211","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clinbiochem.2015.07.030","article-title":"KDIGO 2012 clinical practice guideline CKD classification rules out creatinine clearance 24 hour urine collection?","volume":"49","author":"Ognibene","year":"2016","journal-title":"Clin Biochem"},{"key":"R131-6-20210211","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1111\/ajt.13908","article-title":"Estimated or measured GFR in living kidney donors work-up?","volume":"16","author":"Gaillard","year":"2016","journal-title":"Am J Transplant"},{"key":"R132-6-20210211","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/ndt\/gft509","article-title":"Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test","volume":"29","author":"Fan","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R133-6-20210211","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"R134-6-20210211","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"R135-6-20210211","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"key":"R136-6-20210211","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1001\/jama.2012.3954","article-title":"Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate","volume":"307","author":"Matsushita","year":"2012","journal-title":"JAMA"},{"key":"R137-6-20210211","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N Engl J Med"},{"key":"R138-6-20210211","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.2012.16817","article-title":"Age and association of kidney measures with mortality and end-stage renal disease","volume":"308","author":"Hallan","year":"2012","journal-title":"JAMA"},{"key":"R139-6-20210211","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.ajkd.2015.01.019","article-title":"A prospective controlled study of living kidney donors: three-year follow-up","volume":"66","author":"Kasiske","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R140-6-20210211","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa0804883","article-title":"Long-term consequences of kidney donation","volume":"360","author":"Ibrahim","year":"2009","journal-title":"N Engl J Med"},{"key":"R141-6-20210211","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/sj.ki.5001819","article-title":"Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis, and meta-regression","volume":"70","author":"Garg","year":"2006","journal-title":"Kidney Int"},{"key":"R142-6-20210211","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1111\/j.1440-1797.2009.01223.x","article-title":"The CARI guidelines. Donor renal function","volume":"15","author":"Cohney","year":"2010","journal-title":"Nephrology (Carlton"},{"key":"R143-6-20210211","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1172\/JCI80818","article-title":"Benign hyperfiltration after living kidney donation","volume":"125","author":"Blantz","year":"2015","journal-title":"J Clin Invest"},{"key":"R144-6-20210211","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI78885","article-title":"Longitudinal study of living kidney donor glomerular dynamics after nephrectomy","volume":"125","author":"Lenihan","year":"2015","journal-title":"J Clin Invest"},{"key":"R145-6-20210211","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00007890-200108150-00015","article-title":"No evidence of accelerated loss of kidney function in living kidney donors: results from a cross-sectional follow-up","volume":"72","author":"Fehrman-Ekholm","year":"2001","journal-title":"Transplantation"},{"key":"R146-6-20210211","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1432-2277.2012.01439.x","article-title":"Very long-term follow-up of living kidney donors","volume":"25","author":"Fournier","year":"2012","journal-title":"Transpl Int"},{"key":"R147-6-20210211","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1600-6143.2011.03609.x","article-title":"Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation","volume":"11","author":"Cherikh","year":"2011","journal-title":"Am J Transplant"},{"key":"R148-6-20210211","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/ajt.13173","article-title":"Consensus conference on best practices in live kidney donation: recommendations to optimize education, access, and care","volume":"15","author":"LaPointe Rudow","year":"2015","journal-title":"Am J Transplant"},{"key":"R149-6-20210211","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ki.2013.359","article-title":"Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney","volume":"85","author":"Wang","year":"2014","journal-title":"Kidney Int"},{"key":"R150-6-20210211","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2490-9-19","article-title":"Normal kidney size and its influencing factors\u2014a 64-slice MDCT study of 1.040 asymptomatic patients","volume":"9","author":"Glodny","year":"2009","journal-title":"BMC Urol"},{"key":"R151-6-20210211","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2214\/ajr.160.1.8416654","article-title":"Kidney dimensions at sonography: correlation with age, sex, and habitus in 665 adult volunteers","volume":"160","author":"Emamian","year":"1993","journal-title":"AJR Am J Roentgenol"},{"key":"R152-6-20210211","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/00007890-200011150-00016","article-title":"Low absolute glomerular filtration rate in the living kidney donor: a risk factor for graft loss","volume":"70","author":"Norden","year":"2000","journal-title":"Transplantation"},{"key":"R153-6-20210211","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40472-014-0043-4","article-title":"Evaluation of kidney function and structure in potential living kidney donors: implications for the donor and recipient","volume":"2","author":"Zaky","year":"2015","journal-title":"Curr Transpl Rep"},{"key":"R154-6-20210211","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1600-6143.2007.01932.x","article-title":"The medical evaluation of living kidney donors: a survey of US transplant centers","volume":"7","author":"Mandelbrot","year":"2007","journal-title":"Am J Transplant"},{"key":"R155-6-20210211","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.ajkd.2014.01.002","article-title":"Albuminuria: time to focus on accuracy","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R158-6-20210211","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1111\/j.1440-1797.2009.01218.x","article-title":"The CARI guidelines. Donors at risk: proteinuria","volume":"15","author":"Boudville","year":"2010","journal-title":"Nephrology (Carlton"},{"key":"R159-6-20210211","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1681\/ASN.V7112288","article-title":"The evaluation of living renal transplant donors: clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians","volume":"7","author":"Kasiske","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"R160-6-20210211","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMcp012694","article-title":"Clinical practice. Microscopic hematuria","volume":"348","author":"Cohen","year":"2003","journal-title":"N Engl J Med"},{"key":"R161-6-20210211","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.juro.2012.09.078","article-title":"Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline","volume":"188","author":"Davis","year":"2012","journal-title":"J Urol"},{"key":"R162-6-20210211","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1001\/jama.1990.03440180081037","article-title":"Evaluation of hematuria in adults","volume":"263","author":"Sutton","year":"1990","journal-title":"JAMA"},{"key":"R163-6-20210211","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.2011.1141","article-title":"Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease","volume":"306","author":"Vivante","year":"2011","journal-title":"JAMA"},{"key":"R164-6-20210211","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/qjmed\/hch125","article-title":"Asymptomatic isolated microscopic haematuria: long-term follow-up","volume":"97","author":"Chow","year":"2004","journal-title":"QJM"},{"key":"R165-6-20210211","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1742-1241.2007.01659.x","article-title":"Asymptomatic microscopic haematuria in young males","volume":"62","author":"Kovacevic","year":"2008","journal-title":"Int J Clin Pract"},{"key":"R166-6-20210211","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/08035250600652005","article-title":"Analysis of renal biopsies performed in children with abnormal findings in urinary mass screening","volume":"95","author":"Lee","year":"2006","journal-title":"Acta Paediatr"},{"key":"R167-6-20210211","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s00467-005-1915-8","article-title":"Hematuria and proteinuria in a mass school urine screening test","volume":"20","author":"Park","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"R168-6-20210211","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrneph.2017.43","article-title":"Renal and cardiac assessment of living kidney donor candidates","volume":"13","author":"Lam","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"R169-6-20210211","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1523-1755.2003.00234.x","article-title":"Thin basement membrane nephropathy","volume":"64","author":"Savige","year":"2003","journal-title":"Kidney Int"},{"key":"R170-6-20210211","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/01.tp.0000181098.56617.b2","article-title":"Persistent, asymptomatic, microscopic hematuria in prospective kidney donors","volume":"80","author":"Koushik","year":"2005","journal-title":"Transplantation"},{"key":"R171-6-20210211","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.transproceed.2011.12.008","article-title":"The role of kidney biopsy to determine donation from prospective kidney donors with asymptomatic urinary abnormalities","volume":"44","author":"Choi","year":"2012","journal-title":"Transplant Proc"},{"key":"R172-6-20210211","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","article-title":"X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study","volume":"14","author":"Jais","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R173-6-20210211","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/ki.2011.452","article-title":"Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations","volume":"81","author":"Temme","year":"2012","journal-title":"Kidney Int"},{"key":"R174-6-20210211","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/ndt\/gfn635","article-title":"Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome","volume":"24","author":"Gross","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R175-6-20210211","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.semnephrol.2004.01.001","article-title":"Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome","volume":"24","author":"D'Amico","year":"2004","journal-title":"Semin Nephrol"},{"key":"R176-6-20210211","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0002-9343(01)00659-3","article-title":"The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria","volume":"110","author":"Szeto","year":"2001","journal-title":"Am J Med"},{"key":"R177-6-20210211","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1046\/j.1523-1755.63.6s.2.x","article-title":"Incidence of latent mesangial IgA deposition in renal allograft donors in Japan","volume":"63","author":"Suzuki","year":"2003","journal-title":"Kidney Int"},{"key":"R178-6-20210211","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1600-6143.2010.03077.x","article-title":"Persistent glomerular hematuria in living kidney donors confers a risk of progressive kidney disease in donors after heminephrectomy","volume":"10","author":"Kido","year":"2010","journal-title":"Am J Transplant"},{"key":"R179-6-20210211","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000000918","article-title":"Kidney paired donation protocol for participating donors 2014","volume":"99","author":"Richardson","year":"2015","journal-title":"Transplantation"},{"key":"R180-6-20210211","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1111\/j.1440-1797.2009.01219.x","article-title":"The CARI guidelines. Donors at risk: haematuria","volume":"15","author":"Ierino","year":"2010","journal-title":"Nephrology (Carlton"},{"key":"R181-6-20210211","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy","volume":"24","author":"Savige","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R182-6-20210211","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/ndt\/gfq769","article-title":"Clinical characteristics of potential kidney donors with asymptomatic kidney stones","volume":"26","author":"Lorenz","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R183-6-20210211","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1111\/j.1440-1797.2006.00724.x","article-title":"The CARI guidelines. Kidney stones epidemiology","volume":"12","author":"Hughes","year":"2007","journal-title":"Nephrology (Carlton"},{"key":"R184-6-20210211","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1111\/ajt.12446","article-title":"Risk of kidney stones with surgical intervention in living kidney donors","volume":"13","author":"Thomas","year":"2013","journal-title":"Am J Transplant"},{"key":"R185-6-20210211","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1464-410X.2012.11572.x","article-title":"Incidental renal stones in potential live kidney donors: prevalence, assessment and donation, including role of ex vivo ureteroscopy","volume":"111","author":"Olsburgh","year":"2013","journal-title":"BJU Int"},{"key":"R186-6-20210211","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.juro.2014.05.006","article-title":"Medical management of kidney stones: AUA guideline","volume":"192","author":"Pearle","year":"2014","journal-title":"J Urol"},{"key":"R187-6-20210211","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.eururo.2015.07.040","article-title":"EAU guidelines on diagnosis and conservative management of urolithiasis","volume":"69","author":"T\u00fcrk","year":"2016","journal-title":"Eur Urol"},{"key":"R188-6-20210211","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40620-016-0283-8","article-title":"Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature","volume":"30","author":"Ferraro","year":"2017","journal-title":"J Nephrol"},{"key":"R189-6-20210211","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2215\/CJN.10651110","article-title":"Chronic kidney disease in kidney stone formers","volume":"6","author":"Rule","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R190-6-20210211","doi-asserted-by":"crossref","first-page":"e5287","DOI":"10.1136\/bmj.e5287","article-title":"Kidney stones and kidney function loss: a cohort study","volume":"345","author":"Alexander","year":"2012","journal-title":"BMJ"},{"key":"R191-6-20210211","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.juro.2014.05.117","article-title":"Risk of chronic and end stage kidney disease in patients with nephrolithiasis","volume":"192","author":"Shoag","year":"2014","journal-title":"J Urol"},{"key":"R192-6-20210211","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2215\/CJN.10111014","article-title":"Nephrolithiasis as a risk factor for CKD: the Atherosclerosis Risk in Communities Study","volume":"10","author":"Kummer","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R193-6-20210211","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.juro.2007.10.022","article-title":"Living renal donor allograft lithiasis: a review of stone related morbidity in donors and recipients","volume":"179","author":"Strang","year":"2008","journal-title":"J Urol"},{"key":"R194-6-20210211","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7326\/0003-4819-158-7-201304020-00005","article-title":"Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline","volume":"158","author":"Fink","year":"2013","journal-title":"Ann Intern Med"},{"key":"R195-6-20210211","doi-asserted-by":"crossref","first-page":"659","DOI":"10.7326\/M13-2908","article-title":"Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians","volume":"161","author":"Qaseem","year":"2014","journal-title":"Ann Intern Med"},{"key":"R197-6-20210211","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"key":"R198-6-20210211","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R199-6-20210211","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11926-012-0240-z","article-title":"Regulation of uric acid excretion by the kidney","volume":"14","author":"Lipkowitz","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"R200-6-20210211","doi-asserted-by":"crossref","first-page":"e50046","DOI":"10.1371\/journal.pone.0050046","article-title":"Reduced glomerular function and prevalence of gout: NHANES 2009-10","volume":"7","author":"Krishnan","year":"2012","journal-title":"PLoS One"},{"key":"R201-6-20210211","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.ajkd.2013.01.027","article-title":"A prospective controlled study of kidney donors: baseline and 6-month follow-up","volume":"62","author":"Kasiske","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R202-6-20210211","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/HYPERTENSIONAHA.115.06608","article-title":"Cardiovascular effects of unilateral nephrectomy in living kidney donors","volume":"67","author":"Moody","year":"2016","journal-title":"Hypertension"},{"key":"R203-6-20210211","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.ajkd.2015.01.017","article-title":"Gout after living kidney donation: a matched cohort study","volume":"65","author":"Lam","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R204-6-20210211","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000381291","article-title":"Gout after living kidney donation: correlations with demographic traits and renal complications","volume":"41","author":"Lam","year":"2015","journal-title":"Am J Nephrol"},{"key":"R205-6-20210211","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1515\/cclm-2015-0523","article-title":"Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis","volume":"54","author":"Braga","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"R206-6-20210211","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken"},{"key":"R207-6-20210211","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3899\/jrheum.140462","article-title":"Treatment of gout patients with impairment of renal function: a systematic literature review","volume":"92","author":"van Echteld","year":"2014","journal-title":"J Rheumatol Suppl"},{"key":"R208-6-20210211","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.kint.2016.05.012","article-title":"Abnormalities in biomarkers of mineral and bone metabolism in kidney donors","volume":"90","author":"Kasiske","year":"2016","journal-title":"Kidney Int"},{"key":"R209-6-20210211","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.ajkd.2011.09.019","article-title":"Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation","volume":"59","author":"Young","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R210-6-20210211","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.ajkd.2012.01.013","article-title":"Fracture risk in living kidney donors: a matched cohort study","volume":"59","author":"Garg","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R211-6-20210211","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1097\/01.ASN.0000077346.92039.9C","article-title":"Blood pressure evaluation among older living kidney donors","volume":"14","author":"Textor","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R212-6-20210211","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/HJH.0b013e328363e964","article-title":"European Society of Hypertension position paper on ambulatory blood pressure monitoring","volume":"31","author":"O'Brien","year":"2013","journal-title":"J Hypertens"},{"key":"R213-6-20210211","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"R214-6-20210211","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1111\/j.1440-1797.2009.01220.x","article-title":"The CARI guidelines. Donors at risk: hypertension","volume":"15","author":"Ierino","year":"2010","journal-title":"Nephrology (Carlton"},{"key":"R215-6-20210211","first-page":"293","article-title":"European renal best practice guideline on the management and evaluation of the kidney donor and recipient","volume":"34","author":"Pascual","year":"2014","journal-title":"Nefrologia"},{"key":"R216-6-20210211","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/HYPERTENSIONAHA.113.02741","article-title":"Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome","volume":"63","author":"Stergiou","year":"2014","journal-title":"Hypertension"},{"key":"R217-6-20210211","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/HJH.0b013e32835fa5dc","article-title":"Target organ damage and masked hypertension in the general population: the Finn-Home study","volume":"31","author":"Hanninen","year":"2013","journal-title":"J Hypertens"},{"key":"R218-6-20210211","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2261-12-93","article-title":"Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension","volume":"12","author":"Aljadhey","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"R219-6-20210211","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1524-6175.2006.05939.x","article-title":"Drug interactions and drugs that affect blood pressure","volume":"8","author":"Elliott","year":"2006","journal-title":"J Clin Hypertens (Greenwich"},{"key":"R220-6-20210211","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/CRD.0b013e31821ddcf4","article-title":"The effects of nonsteroidal anti-inflammatory drugs on blood pressure in hypertensive patients","volume":"19","author":"Snowden","year":"2011","journal-title":"Cardiol Rev"},{"key":"R221-6-20210211","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.jacc.2013.11.003","article-title":"2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Eckel","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R222-6-20210211","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1097\/01.ASN.0000031805.09178.37","article-title":"Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP)","volume":"13","author":"Young","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R223-6-20210211","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jama.287.8.1003","article-title":"Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study","volume":"287","author":"Vasan","year":"2002","journal-title":"JAMA"},{"key":"R224-6-20210211","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-145-3-200608010-00006","article-title":"Meta-analysis: risk for hypertension in living kidney donors","volume":"145","author":"Boudville","year":"2006","journal-title":"Ann Intern Med"},{"key":"R225-6-20210211","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/TP.0b013e31817ba9e3","article-title":"Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada","volume":"86","author":"Garg","year":"2008","journal-title":"Transplantation"},{"key":"R226-6-20210211","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000365157","article-title":"Understanding antihypertensive medication use after living kidney donation through linked national registry and pharmacy claims data","volume":"40","author":"Lentine","year":"2014","journal-title":"Am J Nephrol"},{"key":"R227-6-20210211","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/01.TP.0000436731.23554.5e","article-title":"Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors","volume":"97","author":"Lentine","year":"2014","journal-title":"Transplantation"},{"key":"R228-6-20210211","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1000950","article-title":"Racial variation in medical outcomes among living kidney donors","volume":"363","author":"Lentine","year":"2010","journal-title":"N Engl J Med"},{"key":"R229-6-20210211","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-6143.2012.04303.x","article-title":"Medical outcomes in African American live kidney donors: a matched cohort study","volume":"13","author":"Doshi","year":"2013","journal-title":"Am J Transplant"},{"key":"R230-6-20210211","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1503\/cmaj.121468","article-title":"Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"185","author":"Lv","year":"2013","journal-title":"CMAJ"},{"key":"R231-6-20210211","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"R232-6-20210211","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"R233-6-20210211","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/archinte.168.8.832","article-title":"Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans","volume":"168","author":"Appel","year":"2008","journal-title":"Arch Intern Med"},{"key":"R234-6-20210211","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa0910975","article-title":"Intensive blood-pressure control in hypertensive chronic kidney disease","volume":"363","author":"Appel","year":"2010","journal-title":"N Engl J Med"},{"key":"R235-6-20210211","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease","volume":"22","author":"Friedman","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R236-6-20210211","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1681\/ASN.2010121234","article-title":"Genetic variation in APOL1 associates with younger age at hemodialysis initiation","volume":"22","author":"Kanji","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R237-6-20210211","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R238-6-20210211","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa","year":"2013","journal-title":"N Engl J Med"},{"key":"R239-6-20210211","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(05)17789-7","article-title":"Chronic kidney disease: the global challenge","volume":"365","author":"Meguid El Nahas","year":"2005","journal-title":"Lancet"},{"key":"R240-6-20210211","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2215\/CJN.02740409","article-title":"The science of stewardship: due diligence for kidney donors and kidney function in living kidney donation\u2014evaluation, determinants, and implications for outcomes","volume":"4","author":"Poggio","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R241-6-20210211","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1523-1755.2005.67136.x","article-title":"Metabolic demand and renal mass supply affecting the early graft function after living donor kidney transplantation","volume":"67","author":"Oh","year":"2005","journal-title":"Kidney Int"},{"key":"R242-6-20210211","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1600-6143.2008.02355.x","article-title":"Nephrectomy elicits impact of age and BMI on renal hemodynamics: lower postdonation reserve capacity in older or overweight kidney donors","volume":"8","author":"Rook","year":"2008","journal-title":"Am J Transplant"},{"key":"R243-6-20210211","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1440-1797.2007.00852.x","article-title":"Risk factors for MDRD-GFR of less than 60 mL\/min per 1.73 m2 in former kidney donors","volume":"12","author":"Lee","year":"2007","journal-title":"Nephrology (Carlton"},{"key":"R244-6-20210211","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0041-1345(03)00174-X","article-title":"Kidney transplantation with living donors: nine years of follow-up of 628 living donors","volume":"35","author":"Gracida","year":"2003","journal-title":"Transplant Proc"},{"key":"R245-6-20210211","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/01.TP.0000128168.97735.B3","article-title":"Blood pressure and renal function after kidney donation from hypertensive living donors","volume":"78","author":"Textor","year":"2004","journal-title":"Transplantation"},{"key":"R247-6-20210211","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"R249-6-20210211","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cjca.2013.11.004","article-title":"Obesity, diabetes, and the metabolic syndrome: the global scourge","volume":"30","author":"Padwal","year":"2014","journal-title":"Can J Cardiol"},{"key":"R250-6-20210211","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s13679-016-0233-8","article-title":"Global changes in food supply and the obesity epidemic","volume":"5","author":"Zobel","year":"2016","journal-title":"Curr Obes Rep"},{"key":"R252-6-20210211","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1111\/j.1440-1797.2009.01222.x","article-title":"The CARI guidelines. Donors at risk: impaired glucose tolerance","volume":"15","author":"Boudville","year":"2010","journal-title":"Nephrology (Carlton"},{"key":"R254-6-20210211","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S2213-8587(16)30328-X","article-title":"The need for international consensus on prediabetes","volume":"5","author":"Makaroff","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R255-6-20210211","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R256-6-20210211","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.suc.2005.09.002","article-title":"Perioperative management of special populations: obesity","volume":"85","author":"DeMaria","year":"2005","journal-title":"Surg Clin North Am"},{"key":"R257-6-20210211","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrneph.2016.75","article-title":"Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis","volume":"12","author":"D'Agati","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"R258-6-20210211","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3109\/03009734.2014.899654","article-title":"Single-centre long-term follow-up of live kidney donors demonstrates preserved kidney function but the necessity of a structured lifelong follow-up","volume":"119","author":"von Zur-Muhlen","year":"2014","journal-title":"Ups J Med Sci"},{"key":"R259-6-20210211","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1111\/j.1440-1797.2009.01221.x","article-title":"The CARI guidelines. Donors at risk: obesity","volume":"15","author":"Isbel","year":"2010","journal-title":"Nephrology (Carlton"},{"key":"R260-6-20210211","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.kint.2016.10.014","article-title":"Obesity increases the risk of end-stage renal disease among living kidney donors","volume":"91","author":"Locke","year":"2017","journal-title":"Kidney Int"},{"key":"R261-6-20210211","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.290.14.1884","article-title":"Lifetime risk for diabetes mellitus in the United States","volume":"290","author":"Narayan","year":"2003","journal-title":"JAMA"},{"key":"R262-6-20210211","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2215\/CJN.07891109","article-title":"Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes","volume":"5","author":"Plantinga","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R263-6-20210211","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/TP.0b013e3181d9e17b","article-title":"The consequences for live kidney donors with preexisting glucose intolerance without diabetic complication: analysis at a single Japanese center","volume":"89","author":"Okamoto","year":"2010","journal-title":"Transplantation"},{"key":"R264-6-20210211","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tabak","year":"2012","journal-title":"Lancet"},{"key":"R265-6-20210211","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S2213-8587(13)70175-X","article-title":"Definition of intervention points in prediabetes","volume":"2","author":"Ferrannini","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R266-6-20210211","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2213-8587(15)00362-9","article-title":"Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study","volume":"4","author":"Ligthart","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R267-6-20210211","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.TP.0000438625.91095.8b","article-title":"Prediabetic living kidney donors have preserved kidney function at 10 years after donation","volume":"97","author":"Chandran","year":"2014","journal-title":"Transplantation"},{"key":"R268-6-20210211","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000441624","article-title":"Metabolic syndrome and smoking are associated with future development of advanced chronic kidney disease in older adults","volume":"6","author":"Zammit","year":"2016","journal-title":"Cardiorenal Med"},{"key":"R269-6-20210211","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.ajkd.2016.02.046","article-title":"Risk factors for rapid kidney function decline among African Americans: the Jackson Heart Study (JHS)","volume":"68","author":"Young","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R270-6-20210211","doi-asserted-by":"crossref","first-page":"e1203","DOI":"10.1136\/bmj.e1203","article-title":"Cardiovascular disease in kidney donors: matched cohort study","volume":"344","author":"Garg","year":"2012","journal-title":"BMJ"},{"key":"R271-6-20210211","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/ajt.12804","article-title":"Quantifying risk of kidney donation: the truth is not out there (yet)","volume":"14","author":"Kaplan","year":"2014","journal-title":"Am J Transplant"},{"key":"R272-6-20210211","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/ki.2014.89","article-title":"Increasing mortality by living kidney donation? The devil is in the details","volume":"85","author":"Amer","year":"2014","journal-title":"Kidney Int"},{"key":"R273-6-20210211","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40472-014-0049-y","article-title":"Infection and cancer screening in potential living donors: best practices to protect the donor and recipient","volume":"2","author":"Kirchner","year":"2015","journal-title":"Curr Transpl Rep"},{"key":"R274-6-20210211","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrneph.2014.159","article-title":"Donor-derived infection\u2014the challenge for transplant safety","volume":"10","author":"Fishman","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"R275-6-20210211","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/1469-0691.12557","article-title":"Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections","volume":"20","author":"Len","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R276-6-20210211","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.idc.2010.02.002","article-title":"Infections transmitted by transplantation","volume":"24","author":"Morris","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"R277-6-20210211","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jcv.2008.06.009","article-title":"BK virus antibody titers and intensity of infections after renal transplantation","volume":"43","author":"Bohl","year":"2008","journal-title":"J Clin Virol"},{"key":"R278-6-20210211","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1600-6143.2005.01000.x","article-title":"Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia","volume":"5","author":"Bohl","year":"2005","journal-title":"Am J Transplant"},{"key":"R279-6-20210211","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1586\/14787210.5.2.295","article-title":"Prevention and management of cytomegalovirus infection in solid-organ transplantation","volume":"5","author":"Mwintshi","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R280-6-20210211","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/TP.0b013e318235c7fc","article-title":"Summary of the British Transplantation Society guidelines for the prevention and management of CMV disease after solid organ transplantation","volume":"92","author":"Andrews","year":"2011","journal-title":"Transplantation"},{"key":"R281-6-20210211","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","article-title":"Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction","volume":"5","author":"Brennan","year":"2005","journal-title":"Am J Transplant"},{"key":"R282-6-20210211","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/TP.0b013e3181e81afc","article-title":"Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes","volume":"90","author":"Spinner","year":"2010","journal-title":"Transplantation"},{"key":"R283-6-20210211","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajt.12095","article-title":"Donor-derived infections in solid organ transplantation","volume":"13","author":"Ison","year":"2013","journal-title":"Am J Transplant"},{"key":"R284-6-20210211","first-page":"1334","article-title":"City, 2009.","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"R285-6-20210211","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/TP.0b013e318236cd02","article-title":"Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation","volume":"92","author":"Garzoni","year":"2011","journal-title":"Transplantation"},{"key":"R286-6-20210211","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/ajt.12666","article-title":"Considerations for screening live kidney donors for endemic infections: a viewpoint on the UNOS policy","volume":"14","author":"Levi","year":"2014","journal-title":"Am J Transplant"},{"key":"R289-6-20210211","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1600-6143.2011.03444.x","article-title":"Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas in transplant working group","volume":"11","author":"Chin-Hong","year":"2011","journal-title":"Am J Transplant"},{"key":"R290-6-20210211","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1111\/j.1600-6143.2012.04205.x","article-title":"Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report","volume":"12","author":"Morris","year":"2012","journal-title":"Am J Transplant"},{"key":"R292-6-20210211","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1097\/00007890-200212270-00001","article-title":"Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation","volume":"74","author":"Feng","year":"2002","journal-title":"Transplantation"},{"key":"R293-6-20210211","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.trre.2010.05.001","article-title":"Review of the use of hepatitis B core antibody-positive kidney donors","volume":"24","author":"Ouseph","year":"2010","journal-title":"Transplant Rev (Orlando"},{"key":"R295-6-20210211","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJM199302183280703","article-title":"Membranoproliferative glomerulonephritis associated with hepatitis C virus infection","volume":"328","author":"Johnson","year":"1993","journal-title":"N Engl J Med"},{"key":"R296-6-20210211","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1034\/j.1399-3062.2002.t01-2-01002.x","article-title":"Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 2: hepatitis C virus)","volume":"4","author":"Natov","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"R297-6-20210211","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1600-6143.2004.00606.x","article-title":"The impact of transplantation with deceased donor hepatitis C-positive kidneys on survival in wait-listed long-term dialysis patients","volume":"4","author":"Abbott","year":"2004","journal-title":"Am J Transplant"},{"key":"R298-6-20210211","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"EASL recommendations on treatment of hepatitis C 2016.","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"R299-6-20210211","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1537-2995.2004.04215.x","article-title":"A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors","volume":"45","author":"Busch","year":"2005","journal-title":"Transfusion"},{"key":"R300-6-20210211","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMc0900837","article-title":"Renal transplantation between HIV-positive donors and recipients","volume":"362","author":"Muller","year":"2010","journal-title":"N Engl J Med"},{"key":"R302-6-20210211","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1600-6143.2011.03597.x","article-title":"Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients","volume":"11","author":"Ison","year":"2011","journal-title":"Am J Transplant"},{"key":"R303-6-20210211","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/ajt.12205","article-title":"Optimal testing of the live organ donor for blood-borne viral pathogens: the report of a consensus conference","volume":"13","author":"Blumberg","year":"2013","journal-title":"Am J Transplant"},{"key":"R305-6-20210211","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/tid.12219","article-title":"Impact of repeat testing of living kidney donors within 14 days of the transplant procedure: a multicenter retrospective survey","volume":"16","author":"Echenique","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"R306-6-20210211","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/rmv.1733","article-title":"Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms","volume":"23","author":"Brennan","year":"2013","journal-title":"Rev Med Virol"},{"key":"R307-6-20210211","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ajt.12004","article-title":"Epstein-Barr virus infection and posttransplant lymphoproliferative disorder","volume":"13","author":"Green","year":"2013","journal-title":"Am J Transplant"},{"key":"R308-6-20210211","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/ajt.12703","article-title":"Epstein-Barr virus infection in adult renal transplant recipients","volume":"14","author":"Morton","year":"2014","journal-title":"Am J Transplant"},{"key":"R309-6-20210211","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s11908-012-0292-2","article-title":"Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment","volume":"14","author":"Beam","year":"2012","journal-title":"Curr Infect Dis Rep"},{"key":"R310-6-20210211","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-6143.2004.00692.x","article-title":"Canadian Society of Transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report","volume":"5","author":"Preiksaitis","year":"2005","journal-title":"Am J Transplant"},{"key":"R311-6-20210211","first-page":"CD003774","article-title":"Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients","volume":"2","author":"Hodson","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R312-6-20210211","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1111\/j.1600-6143.2006.01461.x","article-title":"Transmission of syphilis by solid organ transplantation","volume":"6","author":"Cortes","year":"2006","journal-title":"Am J Transplant"},{"key":"R313-6-20210211","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11908-014-0423-z","article-title":"Current trends in donor testing to detect syphilis infection","volume":"16","author":"Cortez","year":"2014","journal-title":"Curr Infect Dis Rep"},{"key":"R314-6-20210211","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/TP.0000000000000323","article-title":"Improving syphilis screening in deceased organ donors","volume":"99","author":"Theodoropoulos","year":"2015","journal-title":"Transplantation"},{"key":"R315-6-20210211","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1469-0691.12641","article-title":"Mycobacterial infections in solid organ transplant recipients","volume":"20","author":"Meije","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R316-6-20210211","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-6143.2011.03493.x","article-title":"An update on donor-derived disease transmission in organ transplantation","volume":"11","author":"Ison","year":"2011","journal-title":"Am J Transplant"},{"key":"R317-6-20210211","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1086\/597590","article-title":"Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology","volume":"48","author":"Aguado","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R318-6-20210211","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/QCO.0000000000000082","article-title":"Tuberculosis in solid organ transplant candidates and recipients: current and future challenges","volume":"27","author":"Subramanian","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"R319-6-20210211","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10156-013-0578-9","article-title":"Living donor and recipient screening for latent tuberculosis infection by tuberculin skin test and interferon-gamma releasing assay in a country with an intermediate burden of tuberculosis","volume":"19","author":"Moon","year":"2013","journal-title":"J Infect Chemother"},{"key":"R320-6-20210211","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/ctr.12366","article-title":"Impact of urinary tract infection on allograft function after kidney transplantation","volume":"28","author":"Ariza-Heredia","year":"2014","journal-title":"Clin Transplant"},{"key":"R321-6-20210211","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/TP.0b013e3182a04997","article-title":"Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients","volume":"96","author":"Lee","year":"2013","journal-title":"Transplantation"},{"key":"R322-6-20210211","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/1319-2442.148752","article-title":"Strongyloides stercoralis infection in kidney transplant recipients","volume":"26","author":"Abdalhamid","year":"2015","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R323-6-20210211","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/ajt.12670","article-title":"Single donor-derived strongyloidiasis in three solid organ transplant recipients: case series and review of the literature","volume":"14","author":"Le","year":"2014","journal-title":"Am J Transplant"},{"key":"R324-6-20210211","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1111\/ajt.12390","article-title":"Strongyloides stercoralis transmission by kidney transplantation in two recipients from a common donor","volume":"13","author":"Roseman","year":"2013","journal-title":"Am J Transplant"},{"key":"R326-6-20210211","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/ajt.12340","article-title":"Donor-derived Trypanosoma cruzi infection in solid organ recipients in the United States, 2001-2011","volume":"13","author":"Huprikar","year":"2013","journal-title":"Am J Transplant"},{"key":"R334-6-20210211","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/TP.0b013e318254757d","article-title":"Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claims","volume":"94","author":"Lentine","year":"2012","journal-title":"Transplantation"},{"key":"R335-6-20210211","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1111\/ajt.12430","article-title":"Donor cancer transmission in kidney transplantation: a systematic review","volume":"13","author":"Xiao","year":"2013","journal-title":"Am J Transplant"},{"key":"R336-6-20210211","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.tp.0000267919.93425.fb","article-title":"Deceased donors with a past history of malignancy: an organ procurement and transplantation network\/united network for organ sharing update","volume":"84","author":"Kauffman","year":"2007","journal-title":"Transplantation"},{"key":"R337-6-20210211","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(10)70024-3","article-title":"Transmission of donor melanoma by organ transplantation","volume":"11","author":"Strauss","year":"2010","journal-title":"Lancet Oncol"},{"key":"R338-6-20210211","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00007890-199601270-00019","article-title":"Malignant melanoma in organ allograft recipients","volume":"61","author":"Penn","year":"1996","journal-title":"Transplantation"},{"key":"R339-6-20210211","first-page":"53","article-title":"Donor transmitted malignancies","volume":"9","author":"Buell","year":"2004","journal-title":"Ann Transplant"},{"key":"R340-6-20210211","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jama.2016.8465","article-title":"Screening for skin cancer: US preventive services task force recommendation statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"R341-6-20210211","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1600-6143.2011.03565.x","article-title":"Donor-transmitted malignancies in organ transplantation: assessment of clinical risk","volume":"11","author":"Nalesnik","year":"2011","journal-title":"Am J Transplant"},{"key":"R342-6-20210211","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/TP.0000000000001036","article-title":"Risk of nephrectomy in previous living kidney donors","volume":"100","author":"Ordon","year":"2016","journal-title":"Transplantation"},{"key":"R343-6-20210211","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.urology.2005.04.003","article-title":"An update of the Bosniak renal cyst classification system","volume":"66","author":"Israel","year":"2005","journal-title":"Urology"},{"key":"R345-6-20210211","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/TP.0b013e3182875e00","article-title":"Kidneys from donors with incidental renal tumors: should they be considered acceptable option for transplantation?","volume":"95","author":"Musquera","year":"2013","journal-title":"Transplantation"},{"key":"R346-6-20210211","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.transproceed.2012.06.036","article-title":"Organ donors with small renal cancer: report of 3 cases","volume":"44","author":"Valente","year":"2012","journal-title":"Transplant Proc"},{"key":"R347-6-20210211","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/j.1464-410X.2009.08681.x","article-title":"Living-donor renal transplantation of grafts with incidental renal masses after ex-vivo partial nephrectomy","volume":"104","author":"Sener","year":"2009","journal-title":"BJU Int"},{"key":"R348-6-20210211","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.transproceed.2007.02.089","article-title":"Transplantation of a kidney with a renal cell carcinoma after living donation: a case report","volume":"39","author":"Ghafari","year":"2007","journal-title":"Transplant Proc"},{"key":"R350-6-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40472-014-0042-5","article-title":"Evaluation of genetic renal diseases in potential living kidney donors","volume":"2","author":"Kuppachi","year":"2015","journal-title":"Curr Transpl Rep"},{"key":"R351-6-20210211","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"key":"R352-6-20210211","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1681\/ASN.2014030297","article-title":"Imaging-based diagnosis of autosomal dominant polycystic kidney disease","volume":"26","author":"Pei","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R353-6-20210211","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneph.2014.104","article-title":"Renal transplantation in autosomal dominant polycystic kidney disease","volume":"10","author":"Kanaan","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"R354-6-20210211","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R355-6-20210211","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/TP.0000000000000466","article-title":"Genetic testing in the assessment of living related kidney donors at risk of autosomal dominant polycystic kidney disease","volume":"99","author":"Simms","year":"2015","journal-title":"Transplantation"},{"key":"R356-6-20210211","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/humu.22103","article-title":"Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients","volume":"33","author":"Audrezet","year":"2012","journal-title":"Hum Mutat"},{"key":"R357-6-20210211","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1681\/ASN.2006121387","article-title":"Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease","volume":"18","author":"Rossetti","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R358-6-20210211","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.ajkd.2015.04.046","article-title":"Testing for high-risk APOL1 alleles in potential living kidney donors","volume":"66","author":"Riella","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R359-6-20210211","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1111\/ajt.14035","article-title":"APOL1-associated end-stage renal disease in a living kidney transplant donor","volume":"16","author":"Zwang","year":"2016","journal-title":"Am J Transplant"},{"key":"R360-6-20210211","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am J Transplant"},{"key":"R361-6-20210211","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/TP.0000000000000969","article-title":"APOL1 genotype and kidney transplantation outcomes from deceased African American donors","volume":"100","author":"Freedman","year":"2016","journal-title":"Transplantation"},{"key":"R362-6-20210211","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1053\/j.ajkd.2013.12.014","article-title":"APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair","volume":"63","author":"Kofman","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R363-6-20210211","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/TP.0b013e31822eec39","article-title":"African American living-kidney donors should be screened for APOL1 risk alleles","volume":"92","author":"Cohen","year":"2011","journal-title":"Transplantation"},{"key":"R364-6-20210211","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/tri.12088","article-title":"Health outcomes among non-Caucasian living kidney donors: knowns and unknowns","volume":"26","author":"Lentine","year":"2013","journal-title":"Transpl Int"},{"key":"R365-6-20210211","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1526924816654608","article-title":"Introducing genetic tests with uncertain implications in living donor kidney transplantation: ApoL1 as a case study","volume":"26","author":"Ross","year":"2016","journal-title":"Prog Transplant"},{"key":"R366-6-20210211","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/TP.0000000000000970","article-title":"The real world impact of APOL1 variants on kidney transplantation","volume":"100","author":"Chandraker","year":"2016","journal-title":"Transplantation"},{"key":"R367-6-20210211","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/ki.2015.16","article-title":"Should kidney donors be genotyped for APOL1 risk alleles?","volume":"87","author":"Freedman","year":"2015","journal-title":"Kidney Int"},{"key":"R368-6-20210211","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1097\/TP.0000000000000733","article-title":"Race, relationship and renal diagnoses after living kidney donation","volume":"99","author":"Lentine","year":"2015","journal-title":"Transplantation"},{"key":"R369-6-20210211","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/ajt.14173","article-title":"Integrating APOL-1 gene variants into renal transplantation: considerations arising from the American Society of Transplantation expert conference","volume":"17","author":"Newell","year":"2017","journal-title":"Am J Transplant"},{"key":"R370-6-20210211","doi-asserted-by":"crossref","first-page":"576","DOI":"10.7861\/clinmedicine.15-6-576","article-title":"Isolated microscopic haematuria of glomerular origin: clinical significance and diagnosis in the 21st century","volume":"15","author":"Chan","year":"2015","journal-title":"Clin Med (Lond"},{"key":"R371-6-20210211","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ki.2014.229","article-title":"The 2014 international workshop on Alport syndrome","volume":"86","author":"Miner","year":"2014","journal-title":"Kidney Int"},{"key":"R372-6-20210211","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrneph.2010.122","article-title":"Living donor kidney transplantation in patients with hereditary nephropathies","volume":"6","author":"Niaudet","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"R373-6-20210211","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1681\/ASN.2008090984","article-title":"The renal lesions of Alport syndrome","volume":"20","author":"Heidet","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R374-6-20210211","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ndt\/gfv325","article-title":"Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis","volume":"31","author":"Gast","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"R375-6-20210211","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00467-015-3302-4","article-title":"Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy","volume":"31","author":"Weber","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"R376-6-20210211","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/ndt\/gfn779","article-title":"Women with Alport syndrome: risks and rewards of kidney donation","volume":"24","author":"Kashtan","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R377-6-20210211","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jacc.2016.05.090","article-title":"Genetic screening of Anderson-Fabry disease in probands referred from multispecialty clinics","volume":"68","author":"Favalli","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R378-6-20210211","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000167493","article-title":"Involvement of renal allograft by Fabry's disease","volume":"7","author":"Popli","year":"1987","journal-title":"Am J Nephrol"},{"key":"R379-6-20210211","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/ndt\/gfr771","article-title":"Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice","volume":"27","author":"Rood","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R380-6-20210211","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ackd.2014.06.001","article-title":"Familial FSGS","volume":"21","author":"Pollak","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"R381-6-20210211","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.2014050489","article-title":"A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome","volume":"26","author":"Sadowski","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R382-6-20210211","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0272-6386(99)70435-X","article-title":"Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation","volume":"33","author":"Winn","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R383-6-20210211","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1053\/ajkd.2002.36938","article-title":"Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor","volume":"40","author":"Donne","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R384-6-20210211","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R385-6-20210211","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/jmg.39.12.882","article-title":"Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy","volume":"39","author":"Hart","year":"2002","journal-title":"J Med Genet"},{"key":"R386-6-20210211","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ng.2543","article-title":"Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing","volume":"45","author":"Kirby","year":"2013","journal-title":"Nat Genet"},{"key":"R387-6-20210211","first-page":"1155","article-title":"Incidence of sickle cell trait\u2014United States, 2010","volume":"63","author":"Ojodu","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R388-6-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12687-014-0195-z","article-title":"Haemoglobinopathies in eastern Indian states: a demographic evaluation","volume":"6","author":"Nagar","year":"2015","journal-title":"J Community Genet"},{"key":"R389-6-20210211","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/asheducation-2010.1.418","article-title":"Sickle-cell trait: novel clinical significance","volume":"2010","author":"Key","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R390-6-20210211","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3949\/ccjm.82a.14029","article-title":"Genitourinary manifestations of sickle cell disease","volume":"82","author":"Gebreselassie","year":"2015","journal-title":"Cleve Clin J Med"},{"key":"R391-6-20210211","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1432-2277.2007.00611.x","article-title":"Screening for sickle trait among potential live kidney donors: policies and practices in US transplant centers","volume":"21","author":"Reese","year":"2008","journal-title":"Transpl Int"},{"key":"R392-6-20210211","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/ajt.13970","article-title":"Screening of living kidney donors for genetic diseases using a comprehensive genetic testing strategy","volume":"17","author":"Thomas","year":"2017","journal-title":"Am J Transplant"},{"key":"R395-6-20210211","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(13)60741-2","article-title":"Pre-eclampsia and the risk of kidney disease","volume":"382","author":"Vikse","year":"2013","journal-title":"Lancet"},{"key":"R396-6-20210211","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2009.12.036","article-title":"Kidney disease after preeclampsia: a systematic review and meta-analysis","volume":"55","author":"McDonald","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R397-6-20210211","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0706790","article-title":"Preeclampsia and the risk of end-stage renal disease","volume":"359","author":"Vikse","year":"2008","journal-title":"N Engl J Med"},{"key":"R398-6-20210211","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1503\/cmaj.120230","article-title":"Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study","volume":"185","author":"Wang","year":"2013","journal-title":"CMAJ"},{"key":"R399-6-20210211","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1210\/jc.2014-4474","article-title":"Gestational diabetes mellitus is a significant risk factor for long-term maternal renal disease","volume":"100","author":"Beharier","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R401-6-20210211","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1408932","article-title":"Gestational hypertension and preeclampsia in living kidney donors","volume":"372","author":"Garg","year":"2015","journal-title":"N Engl J Med"},{"key":"R402-6-20210211","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1600-6143.2008.02427.x","article-title":"Pregnancy and birth after kidney donation: the Norwegian experience","volume":"9","author":"Reisaeter","year":"2009","journal-title":"Am J Transplant"},{"key":"R403-6-20210211","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1600-6143.2009.02548.x","article-title":"Pregnancy outcomes after kidney donation","volume":"9","author":"Ibrahim","year":"2009","journal-title":"Am J Transplant"},{"key":"R404-6-20210211","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta16310","article-title":"Interventions to reduce or prevent obesity in pregnant women: a systematic review","volume":"16","author":"Thangaratinam","year":"2012","journal-title":"Health Technol Assess"},{"key":"R405-6-20210211","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/aogs.12467","article-title":"Effect of diet- and lifestyle-based metabolic risk-modifying interventions on preeclampsia: a meta-analysis","volume":"93","author":"Allen","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R406-6-20210211","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0028-2243(88)90130-X","article-title":"Hydronephrosis during pregnancy: a literature survey","volume":"27","author":"Rasmussen","year":"1988","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R407-6-20210211","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1056\/NEJMoa1408932","article-title":"Gestational hypertension and preeclampsia in living kidney donors","volume":"372","author":"Garg","year":"2015","journal-title":"N Engl J Med"},{"key":"R408-6-20210211","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/tri.12154","article-title":"Predonation psychosocial evaluation of living kidney and liver donor candidates: a systematic literature review","volume":"27","author":"Duerinckx","year":"2014","journal-title":"Transpl Int"},{"key":"R409-6-20210211","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1111\/j.1440-1797.2009.01213.x","article-title":"The CARI guidelines. Psychosocial care of living kidney donors","volume":"15","author":"van Hardeveld","year":"2010","journal-title":"Nephrology (Carlton"},{"key":"R410-6-20210211","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1034\/j.1600-6143.2003.00019.x","article-title":"The living anonymous kidney donor: lunatic or saint?","volume":"3","author":"Henderson","year":"2003","journal-title":"Am J Transplant"},{"key":"R411-6-20210211","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/TP.0b013e31829282eb","article-title":"Unspecified kidney donation\u2014a review of principles, practice and potential","volume":"95","author":"Sharif","year":"2013","journal-title":"Transplantation"},{"key":"R412-6-20210211","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1399-0012.2011.01578.x","article-title":"\u201cIt was just an unconditional gift.\u201d Self reflections of non-directed living kidney donors","volume":"26","author":"Tong","year":"2012","journal-title":"Clin Transplant"},{"key":"R413-6-20210211","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1600-6143.2010.03424.x","article-title":"The long-term quality of life of living kidney donors: a multicenter cohort study","volume":"11","author":"Clemens","year":"2011","journal-title":"Am J Transplant"},{"key":"R414-6-20210211","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/TP.0b013e318253f1bc","article-title":"Depression diagnoses after living kidney donation: linking U.S. Registry data and administrative claims","volume":"94","author":"Lentine","year":"2012","journal-title":"Transplantation"},{"key":"R415-6-20210211","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1111\/ajt.12434","article-title":"Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study","volume":"13","author":"Gross","year":"2013","journal-title":"Am J Transplant"},{"key":"R416-6-20210211","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1432-2277.2012.01524.x","article-title":"Reduced quality of life in living kidney donors: association with fatigue, societal participation and pre-donation variables","volume":"25","author":"de Groot","year":"2012","journal-title":"Transpl Int"},{"key":"R417-6-20210211","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1111\/ajt.12393","article-title":"Preventive intervention for living donor psychosocial outcomes: feasibility and efficacy in a randomized controlled trial","volume":"13","author":"Dew","year":"2013","journal-title":"Am J Transplant"},{"key":"R418-6-20210211","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1111\/ajt.12906","article-title":"Emotional well-being of living kidney donors: findings from the RELIVE Study","volume":"14","author":"Jowsey","year":"2014","journal-title":"Am J Transplant"},{"key":"R419-6-20210211","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1097\/TP.0000000000000360","article-title":"Satisfaction with life among living kidney donors: a RELIVE study of long-term donor outcomes","volume":"98","author":"Messersmith","year":"2014","journal-title":"Transplantation"},{"key":"R420-6-20210211","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1111\/ajt.13453","article-title":"The course and predictors of health-related quality of life in living kidney donors: a systematic review and meta-analysis","volume":"15","author":"Wirken","year":"2015","journal-title":"Am J Transplant"},{"key":"R421-6-20210211","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/TP.0b013e318185ffc9","article-title":"","volume":"86","year":"2008","journal-title":"Transplantation"},{"key":"R422-6-20210211","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/tri.12481","article-title":"Psychosocial impact of pediatric living-donor kidney and liver transplantation on recipients, donors, and the family: a systematic review","volume":"28","author":"Thys","year":"2015","journal-title":"Transpl Int"},{"key":"R423-6-20210211","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.ajkd.2011.11.043","article-title":"The motivations and experiences of living kidney donors: a thematic synthesis","volume":"60","author":"Tong","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R424-6-20210211","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.2215\/CJN.07120714","article-title":"Emotional and financial experiences of kidney donors over the past 50 Years: The RELIVE study","volume":"10","author":"Jacobs","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R425-6-20210211","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1111\/j.1600-6143.2006.01567.x","article-title":"Psychosocial health of living kidney donors: a systematic review","volume":"6","author":"Clemens","year":"2006","journal-title":"Am J Transplant"},{"key":"R426-6-20210211","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/ndt\/gfl069","article-title":"The direct and indirect economic costs incurred by living kidney donors\u2014a systematic review","volume":"21","author":"Clarke","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R427-6-20210211","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/ajt.13591","article-title":"Direct and indirect costs following living kidney donation: findings from the KDOC study","volume":"16","author":"Rodrigue","year":"2016","journal-title":"Am J Transplant"},{"key":"R428-6-20210211","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/ajt.12662","article-title":"Economic consequences incurred by living kidney donors: a Canadian multi-center prospective study","volume":"14","author":"Klarenbach","year":"2014","journal-title":"Am J Transplant"},{"key":"R429-6-20210211","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1111\/ajt.13286","article-title":"Predonation direct and indirect costs incurred by adults who donated a kidney: findings from the KDOC study","volume":"15","author":"Rodrigue","year":"2015","journal-title":"Am J Transplant"},{"key":"R430-6-20210211","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/ajt.13232","article-title":"Living and deceased organ donation should be financially neutral acts","volume":"15","author":"Delmonico","year":"2015","journal-title":"Am J Transplant"},{"key":"R431-6-20210211","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1111\/j.1600-6143.2009.02829.x","article-title":"Reimbursing live organ donors for incurred non-medical expenses: a global perspective on policies and programs","volume":"9","author":"Sickand","year":"2009","journal-title":"Am J Transplant"},{"key":"R432-6-20210211","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.2215\/CJN.01000115","article-title":"Living-donor kidney transplantation: reducing financial barriers to live kidney donation-recommendations from a Consensus Conference","volume":"10","author":"Tushla","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R433-6-20210211","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jhealeco.2013.10.006","article-title":"Removing financial barriers to organ and bone marrow donation: the effect of leave and tax legislation in the U.S","volume":"33","author":"Lacetera","year":"2014","journal-title":"J Health Econ"},{"key":"R434-6-20210211","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/ajt.12819","article-title":"Experiences obtaining insurance after live kidney donation","volume":"14","author":"Boyarsky","year":"2014","journal-title":"Am J Transplant"},{"key":"R435-6-20210211","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/j.1600-6143.2007.01793.x","article-title":"Insurability of living organ donors: a systematic review","volume":"7","author":"Yang","year":"2007","journal-title":"Am J Transplant"},{"key":"R436-6-20210211","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1600-6143.2009.02679.x","article-title":"Life insurance for living kidney donors: a Canadian undercover investigation","volume":"9","author":"Yang","year":"2009","journal-title":"Am J Transplant"},{"key":"R437-6-20210211","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/ajt.14036","article-title":"Miscommunicating NOTA can be costly to living donors","volume":"17","author":"Mittelman","year":"2017","journal-title":"Am J Transplant"},{"key":"R439-6-20210211","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.transproceed.2008.02.036","article-title":"Impact assessment in living kidney donation: psychosocial aspects in the donor","volume":"40","author":"Frade","year":"2008","journal-title":"Transplant Proc"},{"key":"R440-6-20210211","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/01.TP.0000133307.00604.86","article-title":"Quality of life of living kidney donors in Germany: a survey with the Validated Short Form-36 and Giessen Subjective Complaints List-24 questionnaires","volume":"78","author":"Giessing","year":"2004","journal-title":"Transplantation"},{"key":"R441-6-20210211","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1399-0012.2003.00078.x","article-title":"Remaining experiences of living kidney donors more than 3 yr after early recipient graft loss","volume":"17","author":"Haljamae","year":"2003","journal-title":"Clin Transplant"},{"key":"R442-6-20210211","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00007890-199903150-00013","article-title":"Long-term follow-up of living kidney donors: quality of life after donation","volume":"67","author":"Johnson","year":"1999","journal-title":"Transplantation"},{"key":"R443-6-20210211","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000288159","article-title":"Suicide by related kidney donors following the recipients' death","volume":"51","author":"Weizer","year":"1989","journal-title":"Psychother Psychosom"},{"key":"R444-6-20210211","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.transproceed.2009.05.021","article-title":"EULID project: European living donation and public health","volume":"41","author":"Manyalich","year":"2009","journal-title":"Transplant Proc"},{"key":"R445-6-20210211","doi-asserted-by":"crossref","first-page":"e000202","DOI":"10.1136\/bmjopen-2011-000202","article-title":"Prospective Swiss cohort study of living-kidney donors: study protocol","volume":"1","author":"Thiel","year":"2011","journal-title":"BMJ Open"},{"key":"R446-6-20210211","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.psym.2015.02.001","article-title":"The live donor assessment tool: a psychosocial assessment tool for live organ donors","volume":"56","author":"Iacoviello","year":"2015","journal-title":"Psychosomatics"},{"key":"R447-6-20210211","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1097\/TP.0000000000000771","article-title":"Toward a conceptualization of the content of psychosocial screening in living organ donors: an ethical legal psychological aspects of transplantation consensus","volume":"99","author":"Ismail","year":"2015","journal-title":"Transplantation"},{"key":"R448-6-20210211","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00423-014-1196-4","article-title":"Comparison of the laparoscopic versus open live donor nephrectomy: an overview of surgical complications and outcome","volume":"399","author":"Fonouni","year":"2014","journal-title":"Langenbecks Arch Surg"},{"key":"R449-6-20210211","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s11255-014-0671-8","article-title":"Maximizing the donor pool: left versus right laparoscopic live donor nephrectomy\u2014systematic review and meta-analysis","volume":"46","author":"Liu","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"R451-6-20210211","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.transproceed.2012.07.152","article-title":"The safety and efficacy of laparoscopic donor nephrectomy for renal transplantation: an updated meta-analysis","volume":"45","author":"Yuan","year":"2013","journal-title":"Transplant Proc"},{"key":"R452-6-20210211","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1442-2042.2008.02218.x","article-title":"Guidelines for urological laparoscopic surgery","volume":"16","author":"Tanaka","year":"2009","journal-title":"Int J Urol"},{"key":"R453-6-20210211","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1111\/j.1440-1797.2009.01214.x","article-title":"The CARI guidelines. Surgical techniques in living donor nephrectomy","volume":"15","author":"Gibbons","year":"2010","journal-title":"Nephrology (Carlton"},{"key":"R454-6-20210211","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/TP.0b013e3182a902bd","article-title":"Randomized controlled trial comparing hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy","volume":"97","author":"Dols","year":"2014","journal-title":"Transplantation"},{"key":"R455-6-20210211","first-page":"19","article-title":"Robotic-assisted laparoscopic donor nephrectomy: decreasing length of stay","volume":"15","author":"Cohen","year":"2015","journal-title":"Ochsner J"},{"key":"R456-6-20210211","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.purol.2013.09.024","article-title":"Robotic assisted laparoscopic living donor nephrectomy: preoperative assessment and results of 100 cases","volume":"24","author":"Laplace","year":"2014","journal-title":"Prog Urol"},{"key":"R457-6-20210211","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1007\/s00268-013-2244-x","article-title":"State of the art of robotic surgery in organ transplantation","volume":"37","author":"Tzvetanov","year":"2013","journal-title":"World J Surg"},{"key":"R458-6-20210211","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.urology.2012.08.061","article-title":"Transvaginal hybrid natural orifice transluminal surgery robotic donor nephrectomy: first clinical application","volume":"80","author":"Kaouk","year":"2012","journal-title":"Urology"},{"key":"R459-6-20210211","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.eururo.2011.03.021","article-title":"Feasibility of transvaginal natural orifice transluminal endoscopic surgery-assisted living donor nephrectomy: is kidney vaginal delivery the approach of the future?","volume":"59","author":"Alcaraz","year":"2011","journal-title":"Eur Urol"},{"key":"R460-6-20210211","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1097\/TP.0000000000001327","article-title":"Perioperative events and complications in minimally invasive live donor nephrectomy: a systematic review and meta-analysis","volume":"100","author":"Kortram","year":"2016","journal-title":"Transplantation"},{"key":"R462-6-20210211","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/ctr.12668","article-title":"Trends and outcomes in right vs. left living donor nephrectomy: an analysis of the OPTN\/UNOS database of donor and recipient outcomes\u2014should we be doing more right-sided nephrectomies?","volume":"30","author":"Khalil","year":"2016","journal-title":"Clin Transplant"},{"key":"R463-6-20210211","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/TP.0b013e318198a3a6","article-title":"Laparoscopic donor nephrectomy: a plea for the right-sided approach","volume":"87","author":"Dols","year":"2009","journal-title":"Transplantation"},{"key":"R464-6-20210211","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/tri.12226","article-title":"Can right-sided hand-assisted retroperitoneoscopic donor nephrectomy be advocated above standard laparoscopic donor nephrectomy: a randomized pilot study","volume":"27","author":"Klop","year":"2014","journal-title":"Transpl Int"},{"key":"R465-6-20210211","first-page":"941","article-title":"Renal vascular variants in living related renal donors: evaluation with CT angiography","volume":"95","author":"Apisarnthanarak","year":"2012","journal-title":"J Med Assoc Thai"},{"key":"R466-6-20210211","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00007890-198902000-00045","article-title":"Living-related donors with bilateral multiple renal arteries. A twenty-year experience","volume":"47","author":"Roza","year":"1989","journal-title":"Transplantation"},{"key":"R467-6-20210211","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00007890-198512000-00021","article-title":"100 living-related kidney donor evaluations using digital subtraction angiography","volume":"40","author":"Flechner","year":"1985","journal-title":"Transplantation"},{"key":"R468-6-20210211","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ki.2014.118","article-title":"Shifting paradigms in eligibility criteria for live kidney donation: a systematic review","volume":"87","author":"Ahmadi","year":"2015","journal-title":"Kidney Int"},{"key":"R469-6-20210211","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1600-6143.2011.03918.x","article-title":"Regulatory failure contributing to deaths of live kidney donors","volume":"12","author":"Friedman","year":"2012","journal-title":"Am J Transplant"},{"key":"R470-6-20210211","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.sla.0000193841.43474.ec","article-title":"Fatal and nonfatal hemorrhagic complications of living kidney donation","volume":"243","author":"Friedman","year":"2006","journal-title":"Ann Surg"},{"key":"R471-6-20210211","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/ajt.13142","article-title":"Vascular management during live donor nephrectomy: an online survey among transplant surgeons","volume":"15","author":"Janki","year":"2015","journal-title":"Am J Transplant"},{"key":"R472-6-20210211","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/ajt.14187","article-title":"Defining the tipping point in surgical performance for laparoscopic donor nephrectomy among transplant surgery fellows: a risk-adjusted cumulative summation learning curve analysis","volume":"17","author":"Serrano","year":"2017","journal-title":"Am J Transplant"},{"key":"R475-6-20210211","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/tri.12012","article-title":"Living organ donation practices in Europe\u2014results from an online survey","volume":"26","author":"Lennerling","year":"2013","journal-title":"Transpl Int"},{"key":"R476-6-20210211","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/tri.12097","article-title":"Could minors be living kidney donors? A systematic review of guidelines, position papers and reports","volume":"26","author":"Thys","year":"2013","journal-title":"Transpl Int"},{"key":"R477-6-20210211","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1467-8519.2012.01982.x","article-title":"Living organ procurement from the mentally incompetent: the need for more appropriate guidelines","volume":"28","author":"Van Assche","year":"2014","journal-title":"Bioethics"},{"key":"R479-6-20210211","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/0098858816644719","article-title":"Bartering for a compatible kidney using your incompatible, live kidney donor: legal and ethical issues related to kidney chains","volume":"42","author":"Tenenbaum","year":"2016","journal-title":"Am J Law Med"},{"key":"R480-6-20210211","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/TP.0000000000000080","article-title":"Public attitudes and beliefs about living kidney donation: focus group study","volume":"97","author":"Tong","year":"2014","journal-title":"Transplantation"},{"key":"R481-6-20210211","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2008.65","article-title":"Differences in tolerance for health risk to the living donor among potential donors, recipients, and transplant professionals","volume":"73","author":"Young","year":"2008","journal-title":"Kidney Int"},{"key":"R482-6-20210211","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/152692480801800107","article-title":"Patients' willingness to talk to others about living kidney donation","volume":"18","author":"Rodrigue","year":"2008","journal-title":"Prog Transplant"},{"key":"R483-6-20210211","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2215\/CJN.00950115","article-title":"Living donor kidney transplantation: Improving education outside of transplant centers about live donor transplantation\u2014recommendations from a consensus conference","volume":"10","author":"Waterman","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R486-6-20210211","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/TP.0b013e31824e75a5","article-title":"Live donor champion: finding live kidney donors by separating the advocate from the patient","volume":"93","author":"Garonzik-Wang","year":"2012","journal-title":"Transplantation"},{"key":"R487-6-20210211","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cct.2012.03.015","article-title":"The \u201cHouse Calls\u201d trial: a randomized controlled trial to reduce racial disparities in live donor kidney transplantation: rationale and design","volume":"33","author":"Rodrigue","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"R488-6-20210211","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-6143.2006.01623.x","article-title":"Increasing live donor kidney transplantation: a randomized controlled trial of a home-based educational intervention","volume":"7","author":"Rodrigue","year":"2007","journal-title":"Am J Transplant"},{"key":"R489-6-20210211","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/ajt.12751","article-title":"Home-based family intervention increases knowledge, communication and living donation rates: a randomized controlled trial","volume":"14","author":"Ismail","year":"2014","journal-title":"Am J Transplant"},{"key":"R490-6-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40472-016-0090-0","article-title":"Educating prospective kidney transplant recipients and living donors about living donation: practical and theoretical recommendations for increasing living donation rates","volume":"3","author":"Waterman","year":"2016","journal-title":"Curr Transplant Rep"},{"key":"R491-6-20210211","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1111\/ajt.13961","article-title":"A smartphone app for increasing live organ donation","volume":"16","author":"Kumar","year":"2016","journal-title":"Am J Transplant"},{"key":"R493-6-20210211","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1111\/ajt.13972","article-title":"The ethics of promoting living kidney donation using nonargumentative influence: applications, concerns, and future directions","volume":"16","author":"Allen","year":"2016","journal-title":"Am J Transplant"},{"key":"R494-6-20210211","first-page":"408","article-title":"Ethical guidelines for the evaluation of living organ donors","volume":"47","author":"Wright","year":"2004","journal-title":"Can J Surg"},{"key":"R495-6-20210211","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1097\/TP.0000000000000669","article-title":"Dealing With public solicitation of organs from living donors\u2014an ELPAT view","volume":"99","author":"Frunza","year":"2015","journal-title":"Transplantation"},{"key":"R496-6-20210211","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.trre.2008.02.003","article-title":"Ethical controversies in public solicitations for organs","volume":"22","author":"Wright","year":"2008","journal-title":"Transplant Rev (Orlando"},{"key":"R497-6-20210211","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-6143.2011.03765.x","article-title":"The ethical complexities of online organ solicitation via donor-patient websites: avoiding the \u201cbeauty contest.\u201d","volume":"12","author":"Neidich","year":"2012","journal-title":"Am J Transplant"},{"key":"R498-6-20210211","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/ki.2008.388","article-title":"The Declaration of Istanbul on organ trafficking and transplant tourism.","volume":"74","year":"2008","journal-title":"Kidney Int"},{"key":"R499-6-20210211","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/TP.0b013e318247a7b7","article-title":"Summary of the British Transplantation Society\/Renal Association U.K. guidelines for living donor kidney transplantation","volume":"93","author":"Andrews","year":"2012","journal-title":"Transplantation"},{"key":"R500-6-20210211","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/ajt.13813","article-title":"Financial neutrality for living organ donors: reasoning, rationale, definitions, and implementation strategies","volume":"16","author":"Hays","year":"2016","journal-title":"Am J Transplant"},{"key":"R502-6-20210211","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s40472-017-0135-z","article-title":"Practical approaches to mitigating economic barriers to living kidney donation for patients and programs","volume":"4","author":"LaPointe Rudow","year":"2017","journal-title":"Curr Transpl Rep"},{"key":"R505-6-20210211","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1111\/j.1600-6143.2006.01492.x","article-title":"Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage","volume":"6","author":"Gaston","year":"2006","journal-title":"Am J Transplant"},{"key":"R506-6-20210211","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/ckj\/sfv123","article-title":"Reciprocating living kidney donor generosity: tax credits, health insurance and an outcomes registry","volume":"9","author":"Joshi","year":"2016","journal-title":"Clin Kidney J"},{"key":"R508-6-20210211","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/ajt.14147","article-title":"Providing coverage for the unique lifelong health care needs of living kidney donors within the framework of financial neutrality","volume":"17","author":"Gill","year":"2017","journal-title":"Am J Transplant"},{"key":"R509-6-20210211","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/ajt.13234","article-title":"Between Scylla and Charybdis: charting an ethical course for research into financial incentives for living kidney donation","volume":"15","author":"Fisher","year":"2015","journal-title":"Am J Transplant"},{"key":"R510-6-20210211","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s40472-014-0045-2","article-title":"The rationale for incentives for living donors: an international perspective?","volume":"2","author":"Matas","year":"2015","journal-title":"Curr Transpl Rep"},{"key":"R513-6-20210211","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/TP.0000000000000920","article-title":"Outcomes of live kidney donors who develop end-stage renal disease","volume":"100","author":"Muzaale","year":"2016","journal-title":"Transplantation"},{"key":"R514-6-20210211","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1681\/ASN.2014030302","article-title":"Kidney transplant outcomes for prior living organ donors","volume":"26","author":"Potluri","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R515-6-20210211","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/ajt.13770","article-title":"Changes in deceased donor kidney transplantation one year after KAS implementation","volume":"16","author":"Stewart","year":"2016","journal-title":"Am J Transplant"},{"key":"R516-6-20210211","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.2215\/CJN.01360216","article-title":"Delays in prior living kidney donors receiving priority on the transplant waiting list","volume":"11","author":"Wainright","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R517-6-20210211","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(09)61795-5","article-title":"A new law for allocation of donor organs in Israel","volume":"375","author":"Lavee","year":"2010","journal-title":"Lancet"},{"key":"R518-6-20210211","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/ajt.12001","article-title":"Preliminary marked increase in the national organ donation rate in Israel following implementation of a new organ transplantation law","volume":"13","author":"Lavee","year":"2013","journal-title":"Am J Transplant"},{"key":"R519-6-20210211","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/ctr.12334","article-title":"Living kidney donation: the importance of public education","volume":"28","author":"Tumin","year":"2014","journal-title":"Clin Transplant"},{"key":"R520-6-20210211","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/ajt.13233","article-title":"AST\/ASTS workshop on increasing organ donation in the United States: creating an \u201carc of change\u201d from removing disincentives to testing incentives","volume":"15","author":"Salomon","year":"2015","journal-title":"Am J Transplant"},{"key":"R521-6-20210211","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/j.ajkd.2014.02.019","article-title":"Perspectives of transplant physicians and surgeons on reimbursement, compensation, and incentives for living kidney donors","volume":"64","author":"Tong","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R522-6-20210211","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/TP.0b013e3181b6dfb9","article-title":"Practices and barriers in long-term living kidney donor follow-up: a survey of U.S. transplant centers","volume":"88","author":"Mandelbrot","year":"2009","journal-title":"Transplantation"},{"key":"R523-6-20210211","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.1600-6143.2011.03816.x","article-title":"Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations","volume":"11","author":"Leichtman","year":"2011","journal-title":"Am J Transplant"},{"key":"R524-6-20210211","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1097\/TP.0000000000000670","article-title":"The relevance of Directive 2010\/53\/EU for living organ donation practice: an ELPAT view","volume":"99","author":"Van Assche","year":"2015","journal-title":"Transplantation"},{"key":"R526-6-20210211","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1097\/00005392-199705000-00015","article-title":"Editorial comment: the psychosocial impact of donating a kidney","volume":"157","author":"Litwin","year":"1997","journal-title":"J Urol"},{"key":"R527-6-20210211","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.transproceed.2012.07.106","article-title":"Living donor psychosocial assessment\/follow-up practices in the partners' countries of the ELIPSY project","volume":"44","author":"Manyalich","year":"2012","journal-title":"Transplant Proc"},{"key":"R528-6-20210211","doi-asserted-by":"crossref","first-page":"E300","DOI":"10.1111\/j.1399-0012.2012.01660.x","article-title":"Health care follow-up by live kidney donors more than three yr post-nephrectomy","volume":"26","author":"Weng","year":"2012","journal-title":"Clin Transplant"},{"key":"R529-6-20210211","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/07448481.1989.9938427","article-title":"Adapting the selective periodic health exam to a college-aged population. Joint American Preventive Services Task Force. Canadian Task Force on Health Care Screening","volume":"38","author":"Reith","year":"1989","journal-title":"J Am Coll Health"},{"key":"R530-6-20210211","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/ajt.13282","article-title":"Critical factors associated with missing follow-up data for living kidney donors in the United States","volume":"15","author":"Schold","year":"2015","journal-title":"Am J Transplant"},{"key":"R531-6-20210211","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1111\/j.1600-6143.2011.03815.x","article-title":"When good intentions are not enough: obtaining follow-up data in living kidney donors","volume":"11","author":"Ommen","year":"2011","journal-title":"Am J Transplant"},{"key":"R532-6-20210211","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/j.ackd.2012.03.002","article-title":"Living kidney donor follow-up: state-of-the-art and future directions","volume":"19","author":"Davis","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"key":"R533-6-20210211","doi-asserted-by":"crossref","first-page":"E101","DOI":"10.1111\/j.1399-0012.2011.01558.x","article-title":"Lack of health insurance in living kidney donors","volume":"26","author":"Casagrande","year":"2012","journal-title":"Clin Transplant"},{"key":"R534-6-20210211","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1111\/ajt.13827","article-title":"Health insurance trends in United States living kidney donors (2004 to 2015)","volume":"16","author":"Rodrigue","year":"2016","journal-title":"Am J Transplant"},{"key":"R535-6-20210211","first-page":"90","article-title":"Follow-up reporting for living kidney donors. Abstr 195","volume":"13","author":"Wainright","year":"2013","journal-title":"Am J Transplant"},{"key":"R536-6-20210211","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/ajt.13265","article-title":"Evaluating the Impact of performance improvement initiatives on transplant center reporting compliance and patient follow-up after living kidney donation","volume":"15","author":"Keshvani","year":"2015","journal-title":"Am J Transplant"},{"key":"R538-6-20210211","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2215\/CJN.08530813","article-title":"Better understanding live donor risk through big data","volume":"8","author":"Lentine","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R539-6-20210211","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1111\/ajt.14005","article-title":"The long-term follow-up and support for living organ donors: A center-based initiative founded on developing a community of living donors.","volume":"16","author":"Kulkarni","year":"2016","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000001769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T09:16:18Z","timestamp":1659258978000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201708001-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":476,"journal-issue":{"issue":"8S","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000001769","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}